August 4, 2021
Clinical and Translational Science Award (UM1 Clinical Trial Optional) (PAR-21-293).
Notice of Intent to Publish a Suite of Funding Opportunity Announcements (FOAs) for the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) Program (NOT-TR-21-030)
National Center for Advancing Translational Sciences (NCATS)
NCATS will conduct a technical assistance webinar on Tuesday, September 28, 2021, from 1:00 – 3:00 PM EDT (12PM CDT, 11AM MDT, 10AM PDT) for applicants responding to the Clinical and Translational Science Award (UM1 Clinical Trial Optional) (PAR-21-293).
This webinar will provide an overview of the funding opportunity that invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by (1) developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination; (2) promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally; (3) creating, providing, and disseminating innovative research programs and partnerships across institutions and communities to address health disparities and deliver the benefits of translational science to all; (4) creating and implementing scientific and operational innovations that increase the quality, safety, efficiency, effectiveness, and informativeness of clinical research; (5) providing a national resource for the rapid response to urgent public health needs; and (6) creating, providing, and disseminating CTS training for clinical research professionals of all disciplines on the research team.
During the webinar, staff will provide an overview of the funding opportunity and answer questions from prospective applicants.
Registration for the webinar is required.
All prospective applicants are invited to attend and are highly encouraged to submit questions at least one week in advance to the webinar via email to [email protected]. Questions will be received during the webinar to this mailbox and while an effort will be made to prioritize and include all questions received during the webinar, it is possible that not all questions will be addressed during the event. Questions that are institutionally specific will not be answered during the webinar.
Webinar Information
The webinar will be hosted through the Zoom link below. Registration in advance of the webinar is required.
Date: September 28, 2021
Time: 1:00 to 3:00 PM EDT (12PM CDT, 11AM MDT, 10AM PDT)
Registration required: https://nih.zoomgov.com/webinar/register/WN_QGotDeuhSpGlroFY7N_DSA
Participation in the webinar is optional and is not required to apply to the Clinical and Translational Science Award (UM1 Clinical Trial Optional) (PAR-21-293).
Prospective applicants who are unable to participate in the webinar are encouraged to view the recorded webinar video and presentation slides. These items will be made available on the NCATS CTSA Program Funding Information website approximately one week after the event.
Participants requiring a transcript of the webinar post recording should contact [email protected].
Erica Rosemond, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-594-8927
Email: [email protected]